technotrans SE (FRA:TTR1)

Market Cap	168.55M
Revenue (ttm)	242.18M
Net Income (ttm)	9.83M
Shares Out	n/a
EPS (ttm)	1.37
PE Ratio	17.15
Forward PE	14.07
Dividend	0.53 (2.14%)
Ex-Dividend Date	May 19, 2025

Volume	n/a
Average Volume	367
Open	23.30
Previous Close	24.60
Day's Range	23.30 - 23.30
52-Week Range	13.75 - 25.60
Beta	n/a
RSI	58.45
Earnings Date	Aug 13, 2025

About Intra-Cellular Therapies

technotrans SE operates as a technology and services company worldwide. It develops and produces cooling and temperature control systems, as well as systems for pumping, spraying, filtering, and separating liquids. The company also offers a portfolio of services, such as after-sales service, installation, commissioning, maintenance, repair, and modernization; supplies parts; and engages in the content management and content delivery software. It serves the plastics, energy management, healthcare and analytics, print, and laser markets. The comp...

• Industry: Printing Trades Machinery and Equipment
• Founded: 1970
• Employees: 1,514
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TTR1

Financial Performance

In 2024, technotrans SE's revenue was 238.08 million, a decrease of -9.17% compared to the previous year's 262.12 million. Earnings were 7.32 million, a decrease of -14.26%.